In response to the pandemic, we took on the challenge of leading the fight against Covid-19 in our country. Leveraging our scientific knowledge and expertise in enzymatic solutions, we created the first RT-qPCR and RT-LAMP kits certified by national regulations. We diagnosed over 5 million people, achieving a milestone in precise and timely detection.
Today, as the world moves towards a safer phase, we are expanding our expertise in molecular biology to other applications. We are developing new enzymatic tools to meet the needs of various laboratories and organizations. At Avenire, science and innovation converge to continue making a positive impact on global health.